Table 2.
Cases and clinical features.
| Patients | Age at Diagnosis | Stage (FIGO) | Chemotherapy (No. of Cycles) | SCS [51] | CC [52] | CRS [53] | PFS | OS | Follow-up Status |
|---|---|---|---|---|---|---|---|---|---|
| R1 | 32 | IIIC | 6 | 10 | 2 | NA | 14 | 32 | DOD |
| R2 | 77 | IIIC | 6 | 2 | 1 | NA | 45 | 69 | DOD |
| R3 | 75 | IIC | 7 | 2 | 2 | NA | 15 | 32 | DOD |
| R4 | 61 | IVA | 6 | 3 | 0 | NA | 71 | 71 | AWOD |
| R5 | 68 | IVA | 3 | 10 | 0 | 2 | 10 | 20 | DOD |
| R6 | 44 | IVA | 6 | 10 | 0 | 1 | 25 | 25 | AWOD |
SCS: Surgical complexity score, SCS groups: low = 3 or fewer, intermediate = 4–7, high = 8 or more; CC: Completeness of cytoreduction, CC groups: no disease = 0, disease present up to 0.25 cm = 1, disease present 0.25–2.5 cm = 2, disease greater than 2.5 cm = 3; CRS: Chemotherapy response score, CRS groups: no or minimal tumor response = 1, appreciable tumor response = 2, Complete or near-complete response = 3; NA:. Not available; PFS: Progression Free Survival; OS: Overall Survival; DOD: Dead Of Disease; AWOD: Alive Without Disease.